EDRE
TEVA icon

Edmond de Rothschild (Europe)’s Teva Pharmaceuticals TEVA Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50
Closed -$3K – 254
2016
Q2 		$3K Sell
50
-50
-50% -$2.66K ﹤0.01% 221
2016
Q1 		$5K Buy
+100
New +$5.87K ﹤0.01% 222

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Edmond de Rothschild (Europe)'s TEVA Position: Q3 2016 in Review

Edmond de Rothschild (Europe) sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 50 shares — an estimated $3K sold.

Edmond de Rothschild (Europe) first reported a position in TEVA in Q1 2016 and held it in 2 quarters. The position peaked at $5K in Q1 2016. 796 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Edmond de Rothschild (Europe) reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Edmond de Rothschild (Europe) sold 50 Teva Pharmaceuticals shares in Q3 2016, an estimated $3K.
  • Edmond de Rothschild (Europe) first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Edmond de Rothschild (Europe)'s Teva Pharmaceuticals position peaked at $5K in Q1 2016.
  • 796 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q3 2016, filed 14 Nov 2016.